Cite
HARVARD Citation
Lord, S. et al. (n.d.). Metformin increases 18F-FDG flux and inhibits fatty acid oxidation at clinical doses in breast cancer: Results of a phase 0 clinical trial. European journal of surgical oncology. 42 (11), pp. S230-. [Online].